Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
- PMID: 25595637
- DOI: 10.1016/S1473-3099(14)71071-0
Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
Erratum in
-
Corrections. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.Lancet Infect Dis. 2015 Mar;15(3):263. doi: 10.1016/S1473-3099(14)70967-3. Epub 2015 Jan 20. Lancet Infect Dis. 2015. PMID: 25749220 No abstract available.
Abstract
The epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to gain control of the outbreak and reduce transmission. Several international consortia have been formed in a remarkable worldwide collaborative effort to expedite trials of two candidate Ebola virus vaccines: cAd3-EBOZ and rVSV-EBOV. In parallel, both vaccines are being manufactured in large amounts to enable future rapid deployment for management of the crisis.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
-
Long-term vaccine strategies for Ebola.Lancet Infect Dis. 2015 May;15(5):506-7. doi: 10.1016/S1473-3099(15)70134-9. Epub 2015 Apr 19. Lancet Infect Dis. 2015. PMID: 25932578 No abstract available.
-
Stepped-wedge trial design to evaluate Ebola treatments.Lancet Infect Dis. 2015 Jul;15(7):762-3. doi: 10.1016/S1473-3099(15)00078-X. Lancet Infect Dis. 2015. PMID: 26122441 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials